-
Mashup Score: 16
Exercise oncology clinical trials contribute to the advancement of our scientific knowledge and to the safety and care of patients diagnosed with cancer. Nevertheless, regulatory reviewers and committees may not be familiar with the well-documented long-term health benefits and safety of the regular …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 16
Exercise oncology clinical trials contribute to the advancement of our scientific knowledge and to the safety and care of patients diagnosed with cancer. Nevertheless, regulatory reviewers and committees may not be familiar with the well-documented long-term health benefits and safety of the regular …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 44
Ontario Institute for Cancer Research and London Regional Cancer Program Catalyst Grant.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 13
Merck Sharp & Dohme, a subsidiary of Merck & Co, Rahway, NJ, USA.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 87
Studying survivorship and causes of death in patients with advanced or metastatic cancer remains an important task. We characterize the causes of death among patients with metastatic cancer, across 13 cancer types and 25 non-cancer causes and predict the risk of death after diagnosis from the diagno …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 30
Randomized controlled trials (RCTs) are the gold standard for comparative-effectiveness research (CER). Since the 1980s, there has been a rise in the creation and utilization of large national cancer databases to provide readily accessible “real-world data” (RWD). This review article discusses the r …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 87
Studying survivorship and causes of death in patients with advanced or metastatic cancer remains an important task. We characterize the causes of death among patients with metastatic cancer, across 13 cancer types and 25 non-cancer causes and predict the risk of death after diagnosis from the diagno …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 54Evaluating an academic radiation oncology position - PubMed - 2 month(s) ago
What are the factors that physicians could consider in an academic radiation oncology practice job offer? In this mini-review, we discuss how prospective academic faculty could evaluate the “big 3” domains: (1) the compensation, including the direct and indirect payments; (2) the daily job, includin …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 98Radiation therapy options in kidney cancer - PubMed - 2 month(s) ago
Stereotactic body radiation therapy is a safe and effective treatment option for patients with primary and metastatic RCC.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 74Radiation therapy options in kidney cancer - PubMed - 2 month(s) ago
Stereotactic body radiation therapy is a safe and effective treatment option for patients with primary and metastatic RCC.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
A guide for institutional regulatory committees to evaluate exercise oncology clinical trials https://t.co/ZqORYvsCaB Here are the common questions and answers for scientific review committees, institutional review boards, and data safety monitoring committees: https://t.co/0HzJaddGhZ